Pneumocystosis: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
{{stub}} | {{stub}} | ||
==Pneumocystosis== | |||
<gallery> | |||
File:Pneumocystis.jpg|Pneumocystosis | |||
File:X-ray_and_CT_of_ground_glass_opacities_and_pneumothorax_in_pneumocystis_pneumonia.jpg|X-ray and CT of ground glass opacities and pneumothorax in pneumocystis pneumonia | |||
</gallery> | |||
Revision as of 01:12, 18 February 2025
Pneumocystosis is a form of pneumonia that is caused by the yeast-like fungus Pneumocystis jirovecii. This condition is most commonly seen in individuals with weakened immune systems, such as those with HIV/AIDS, those undergoing chemotherapy, or organ transplant recipients.
Causes
Pneumocystosis is caused by the fungus Pneumocystis jirovecii. This fungus is common in the environment and does not cause illness in healthy individuals. However, in those with weakened immune systems, the fungus can cause a severe and potentially life-threatening pneumonia.
Symptoms
The symptoms of pneumocystosis can vary, but often include fever, cough, shortness of breath, and weight loss. In severe cases, the condition can lead to respiratory failure and death.
Diagnosis
Diagnosis of pneumocystosis typically involves a combination of clinical symptoms, imaging studies such as a chest X-ray or CT scan, and laboratory tests. The definitive diagnosis is made by identifying the fungus in a sample of lung tissue or respiratory secretions.
Treatment
Treatment for pneumocystosis typically involves antifungal medications, such as trimethoprim-sulfamethoxazole. In severe cases, additional treatments such as corticosteroids may be needed to reduce inflammation in the lungs.
Prevention
Prevention of pneumocystosis involves regular medical care for those with weakened immune systems, including the use of prophylactic antifungal medications in some cases.


